A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients.
Stem Cell Reports
; 16(11): 2825-2837, 2021 11 09.
Article
in En
| MEDLINE
| ID: mdl-34678210
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Stem Cells
/
Cell Differentiation
/
Cystic Fibrosis
/
Induced Pluripotent Stem Cells
/
Lung
Limits:
Humans
Language:
En
Year:
2021
Type:
Article